J. Buttner

Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.

Douglas R Martin, J. Callahan, E. Crushell, 2012, Molecular genetics and metabolism.

Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease*

Yoshitomo Hamuro, G. Kornhaber, Y. Hamuro, 2009, The Journal of Biological Chemistry.

Pyrimethamine as a Potential Pharmacological Chaperone for Late-onset Forms of GM2 Gangliosidosis*

T. Stockley, J. Clarke, D. Mahuran, 2007, Journal of Biological Chemistry.

Identification of Pharmacological Chaperones for Gaucher Disease and Characterization of Their Effects on β‐Glucocerebrosidase by Hydrogen/Deuterium Exchange Mass Spectrometry

E. Brown, S. Tuske, G. Kornhaber, 2008, Chembiochem : a European journal of chemical biology.